News

A team led by researchers at Weill Cornell Medicine, the New York Genome Center , Harvard Medical School , Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail... Read more

The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine. The findings provide new insight into the inner workings of the immune system... Read more

Multiplex immunofluorescence image of immune cell-infiltrated human colorectal cancer. Tumor cells are labeled with PKCi (magenta), immune cells are labeled with CD8 (red) and nuclei in white. Image courtesy of Dr. Jorge... Read more

Primary Image Description & Credit: Immunofluorescent images of lungs treated with radiation (left) or no radiation (right). Club cells secrete more anti-immunosuppressive factors when treated with radiation, as seen by... Read more

A team co-led by scientists at Weill Cornell Medicine has revealed in detail how the most common primary eye cancer in adults, uveal melanoma (UM), can progress from a slow-growing, “indolent” state to a lethal metastasizing... Read more

Left: Low and high magnification images of small intestine from healthy mice treated with water or high-fructose corn syrup for 4 weeks. Right: Schematic illustrating how fructose promotes cell survival and increased villi... Read more

A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The... Read more

A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital. The preclinical results... Read more

Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment, according to a phase 2 clinical trial led by researchers... Read more